CME Points: learn more

The European Regional Development Fund (ERDF) provides co-funding to public and private bodies in all EU regions to reduce economic, social and territorial disparities. It aims to make Europe and its regions more competitive and smarter, through innovation and support to small and medium-sized businesses (SMEs), as well as digitization and digital connectivity, greener, low-carbon and resilient, more connected by enhancing mobility, more social, supporting effective and inclusive employment, education, skills, social inclusion and equal access to healthcare, as well as enhancing the role of culture and sustainable tourism, and closer to citizens, supporting locally-led development and sustainable urban development across the EU. INSIGHT is co-funded as part of the Union’s response to the COVID-19 pandemic.

About the Conference

The MIND Foundation’s INSIGHT conference is at the forefront of psychedelic research in medicine and society. Clinicians and entrepreneurs, patients and artists, journalists and regulators, newcomers to the field and seniors meet to rethink psychedelics.

This year’s edition places an additional focus on psychedelic neuroscience and societal topics such as non-clinical forms of use, psychedelics and mindfulness in the business world, the philosophy of psychedelic experience, patient and therapist spiritualities, and learning from indigenous communities.

We offer regular on-site and online tickets, and a contingent of reduced tickets. VIP tickets as well as EFPIA/Industry tickets are available.

Conference Venue


  • Prof. Dr. med. Gerhard Gründer
    Prof. Dr. med. Gerhard Gründer

    Professor and Department Chair

    Central Institute of Mental Health in Mannheim | OVID Health Systems

  • Prof. Dr. Gül Dölen

    Associate Professor of Neuroscience

    Johns Hopkins University

  • Prof. Dr. Thomas Metzinger

    Neurophilosopher and Professor

    Johannes Gutenberg-Universität Mainz

  • Dr. med. Andrea Jungaberle

    Medical Director of OVID Clinic Berlin | Anaesthesiology and Intensive Care, Emergency Medicine | Psychedelic Therapist in the EPIsoDE trial

    OVID Clinic Berlin and MIND Foundation

  • Prof. Dr. Roland Griffiths

    Professor of Psychiatry and Neurosciences

    Johns Hopkins School of Medicine, Center for Psychedelic and Consciousness Research

  • Prof. Dr. Kim Kuypers

    Associate Professor

    Maastricht University

  • Prof. Dr. Matthew Johnson
    Prof. Dr. Matthew Johnson

    Susan Hill Ward Professor of Psychedelics & Consciousness Research

    Johns Hopkins University School of Medicine

  • Prof. Dr. med. Andreas Meyer-Lindenberg

    Director of the Central Institute of Mental Health and Head of the Executive Board

    Central Institute of Mental Health, Germany

  • Dr. Manvir Singh

    Postdoctoral Research Fellow

    Institute for Advanced Study in Toulouse

  • Prof. Dr. David Olson

    Director of the UC Davis Institute for Psychedelics and Neurotherapeutics

    University of California